Occurrence of influenza and bacterial infections in cancer patients receiving radiotherapy in Ghana

dc.contributor.authorArjarquah, A.K
dc.contributor.authorObodai, E.
dc.contributor.authorAnie, H.A.
dc.contributor.authorOsei, M.A.
dc.contributor.authorOdoom, J.K.
dc.contributor.authorBonney, J.H.K.
dc.contributor.authorBehene, E.
dc.contributor.authoret al.
dc.date.accessioned2023-03-13T16:18:50Z
dc.date.available2023-03-13T16:18:50Z
dc.date.issued2022
dc.descriptionResearch Articleen_US
dc.description.abstractAbstract Background Influenza co-infection with bacteria is a leading cause of influenza-related deaths and severe respiratory infections, especially among high-risk groups like cancer patients undergoing treatment. However, acute respiratory infection (ARI)-like symptoms developed by uppertorso cancer (UTC) patients receiving radiotherapy are considered as side-effects of the radiation. Hence influenza and bacterial pathogens implicated in ARI are not investigated. Methods This prospective cohort study examined 85 in-patients with upper-torso cancers undergoing radiotherapy at the National Radiotherapy, Oncology and Nuclear Medicine Centre (NRONMC) of Korle-Bu Teaching Hospital (KBTH) in Accra, Ghana. Eligible patients who consented were recruited into the study from September 2018 to April 2019. Influenza viruses A and B in addition to the following bacteria species Streptococcus pneumonia, Haemophilus influenzae, Neisseria meningitidis and Staphylococcus aureus were detected from oropharyngeal and nasopharyngeal swab specimens collected at three different time points. Presence of respiratory pathogens were investigated by influenza virus isolation in cell culture, bacterial culture, polymerase chain reaction (PCR) and next generation sequencing (NGS) assays. Results Of the 85 eligible participants enrolled into the study, 87% were females. Participants were 17 to 77 years old, with a median age of 49 years. Most of the participants (88%) enrolled had at least one pathogen present. The most prevalent pathogen was N. meningitidis (63.4%), followed by H. influenzae (48.8%), Influenza viruses A and B (32.9%), S. pneumoniae (32.9%) and S. aureus (12.2%). Approximately, 65% of these participants developed ARI-like symptoms. Participants with previous episodes of ARI, did not live alone, HNC and total radiation less than 50 Gy were significantly associated with ARI. All treatment forms were also significantly associated with ARI. Conclusion Data generated from the study suggests that ARI-like symptoms observed among UTC patients receiving radiotherapy in Ghana, could be due to influenza and bacterial single and co-infections in addition to risk factors and not solely the side-effects of radiation as perceived. These findings will be prime importance for diagnosis, prevention, treatment and control for cancer patients who present with such episodes during treatment.en_US
dc.identifier.citationCitation: Arjarquah AK, Obodai E, Anie HA, Osei MA, Odoom JK, Bonney JHK, et al. (2022) Occurrence of influenza and bacterial infections in cancer patients receiving radiotherapy in Ghana. PLoS ONE 17(7): e0271877. https://doi.org/ 10.1371/journal.pone.0271877en_US
dc.identifier.otherhttps://doi.org/10.1371/journal.pone.0271877
dc.identifier.urihttp://ugspace.ug.edu.gh:8080/handle/123456789/38757
dc.language.isoenen_US
dc.publisherPLOS ONEen_US
dc.subjectinfluenzaen_US
dc.subjectbacterialen_US
dc.subjectinfluenza and bacterial infections in cancer patientsen_US
dc.subjectradiotherapyen_US
dc.subjectGhanaen_US
dc.titleOccurrence of influenza and bacterial infections in cancer patients receiving radiotherapy in Ghanaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Occurrence-of-influenza-and-bacterial-infections-in-cancer-patients-receiving-radiotherapy-in-GhanaPLoS-ONE.pdf
Size:
1.11 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: